Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction: A Review of Pharmacologic Agents and Clinical Outcomes.
J Cardiovasc Pharmacol
; 74(4): 297-305, 2019 10.
Article
em En
| MEDLINE
| ID: mdl-31356538
ABSTRACT
The NLRP3 inflammasome is an intracellular, multimeric protein complex that initiates a potent inflammatory response to danger signals. After acute myocardial infarction, NLRP3 inflammasome-dependent inflammation promotes adverse left ventricular remodeling and recurrent atherosclerotic events. Selective and nonselective inhibitors of the NLRP3 inflammasome or its downstream effectors (interleukin-1ß and interleukin-18) may prevent adverse left ventricular remodeling and recurrent atherosclerotic events. In this review, we highlight strategies to inhibit NLRP3 inflammasome activity and their potential roles in the management of acute myocardial infarction.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Fármacos Cardiovasculares
/
Mediadores da Inflamação
/
Inflamassomos
/
Proteína 3 que Contém Domínio de Pirina da Família NLR
/
Inflamação
/
Anti-Inflamatórios
/
Infarto do Miocárdio
Limite:
Animals
/
Humans
Idioma:
En
Revista:
J Cardiovasc Pharmacol
Ano de publicação:
2019
Tipo de documento:
Article
País de afiliação:
Marrocos